Literature DB >> 29888120

Ischemia-reperfusion Injury in the Brain: Mechanisms and Potential Therapeutic Strategies.

Lin L1,2, Wang X2, Yu Z2.   

Abstract

Ischemia-reperfusion injury is a common feature of ischemic stroke, which occurs when blood supply is restored after a period of ischemia. Reperfusion can be achieved either by thrombolysis using thrombolytic reagents such as tissue plasminogen activator (tPA), or through mechanical removal of thrombi. Spontaneous reperfusion also occurs after ischemic stroke. However, despite the beneficial effect of restored oxygen supply by reperfusion, it also causes deleterious effect compared with permanent ischemia. With the recent advancement in endovascular therapy including thrombectomy and thrombus disruption, reperfusion-injury has become an increasingly critical challenge in stroke treatment. It is therefore of extreme importance to understand the mechanisms of ischemia-reperfusion injury in the brain in order to develop effective therapeutics. Accumulating experimental evidence have suggested that the mechanisms of ischemia-reperfusion injury include oxidative stress, leukocyte infiltration, platelet adhesion and aggregation, complement activation, mitochondrial mediated mechanisms, and blood-brain-barrier (BBB) disruption, which altogether ultimately lead to edema or hemorrhagic transformation (HT) in the brain. Potential therapeutic strategies against ischemia-reperfusion injury may be developed targeting these mechanisms. In this review, we briefly discuss the pathophysiology and cellular and molecular mechanisms of cerebral ischemia-reperfusion injury, and potential therapeutic strategies.

Entities:  

Keywords:  Blood-brain-barrier; Complement; Ischemia; Leukocyte; Mitochondria; Oxidative stress; Platelet aggregation; Post-conditioning; Reperfusion; Stroke

Year:  2016        PMID: 29888120      PMCID: PMC5991620          DOI: 10.4172/2167-0501.1000213

Source DB:  PubMed          Journal:  Biochem Pharmacol (Los Angel)        ISSN: 2167-0501


  89 in total

Review 1.  Leukocyte-endothelial cell adhesion: avenues for therapeutic intervention.

Authors:  J Panés; M Perry; D N Granger
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

Review 2.  The role of the complement cascade in ischemia/reperfusion injury: implications for neuroprotection.

Authors:  A L D'Ambrosio; D J Pinsky; E S Connolly
Journal:  Mol Med       Date:  2001-06       Impact factor: 6.354

3.  Remote ischemic post-conditioning reduced brain damage in experimental ischemia/reperfusion injury.

Authors:  Changhong Ren; Mingqing Gao; David Dornbos; Yuchuan Ding; Xianwei Zeng; Yumin Luo; Xunming Ji
Journal:  Neurol Res       Date:  2011-06       Impact factor: 2.448

Review 4.  Ischemia/reperfusion injury: effect of simultaneous inhibition of plasma cascade systems versus specific complement inhibition.

Authors:  Claudia Duehrkop; Robert Rieben
Journal:  Biochem Pharmacol       Date:  2013-12-30       Impact factor: 5.858

Review 5.  Protecting against ischemia-reperfusion injury: antiplatelet drugs, statins, and their potential interactions.

Authors:  Yumei Ye; Jose R Perez-Polo; Yochai Birnbaum
Journal:  Ann N Y Acad Sci       Date:  2010-10       Impact factor: 5.691

6.  Early blood-brain barrier disruption in human focal brain ischemia.

Authors:  Lawrence L Latour; Dong-Wha Kang; Mustapha A Ezzeddine; Julio A Chalela; Steven Warach
Journal:  Ann Neurol       Date:  2004-10       Impact factor: 10.422

7.  In vivo and in vitro characterization of a novel neuroprotective strategy for stroke: ischemic postconditioning.

Authors:  Giuseppe Pignataro; Robert Meller; Koichi Inoue; Andrea N Ordonez; Michelle D Ashley; Zhigang Xiong; Rosaria Gala; Roger P Simon
Journal:  J Cereb Blood Flow Metab       Date:  2007-09-19       Impact factor: 6.200

8.  Nanoparticle-mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia-reperfusion injury.

Authors:  Maram K Reddy; Vinod Labhasetwar
Journal:  FASEB J       Date:  2009-01-05       Impact factor: 5.191

Review 9.  Review, historical context, and clarifications of the NINDS rt-PA stroke trials exclusion criteria: Part 1: rapidly improving stroke symptoms.

Authors:  Steven R Levine; Pooja Khatri; Joseph P Broderick; James C Grotta; Scott E Kasner; Doojin Kim; Brett C Meyer; Peter Panagos; Jose Romano; Phillip Scott
Journal:  Stroke       Date:  2013-07-11       Impact factor: 7.914

10.  In vivo detection of superoxide anion production by the brain using a cytochrome c electrode.

Authors:  R H Fabian; D S DeWitt; T A Kent
Journal:  J Cereb Blood Flow Metab       Date:  1995-03       Impact factor: 6.200

View more
  43 in total

Review 1.  Protective Effects of Curcumin Against Ischemia-Reperfusion Injury in the Nervous System.

Authors:  Kowsar Bavarsad; George E Barreto; Mousa-Al-Reza Hadjzadeh; Amirhossein Sahebkar
Journal:  Mol Neurobiol       Date:  2018-06-09       Impact factor: 5.590

Review 2.  Basement Membrane Changes in Ischemic Stroke.

Authors:  Minkyung Kang; Yao Yao
Journal:  Stroke       Date:  2020-03-03       Impact factor: 7.914

Review 3.  miRNA Involvement in Cerebral Ischemia-Reperfusion Injury.

Authors:  Maria-Adriana Neag; Andrei-Otto Mitre; Codrin-Constantin Burlacu; Andreea-Ioana Inceu; Carina Mihu; Carmen-Stanca Melincovici; Marius Bichescu; Anca-Dana Buzoianu
Journal:  Front Neurosci       Date:  2022-06-10       Impact factor: 5.152

Review 4.  Different Roles of Mitochondria in Cell Death and Inflammation: Focusing on Mitochondrial Quality Control in Ischemic Stroke and Reperfusion.

Authors:  Marianna Carinci; Bianca Vezzani; Simone Patergnani; Peter Ludewig; Katrin Lessmann; Tim Magnus; Ilaria Casetta; Maura Pugliatti; Paolo Pinton; Carlotta Giorgi
Journal:  Biomedicines       Date:  2021-02-09

Review 5.  Repurposing metformin to treat age-related neurodegenerative disorders and ischemic stroke.

Authors:  Sejal Sharma; Saeideh Nozohouri; Bhuvaneshwar Vaidya; Thomas Abbruscato
Journal:  Life Sci       Date:  2021-03-11       Impact factor: 6.780

6.  Acute Administration of Metformin Protects Against Neuronal Apoptosis Induced by Cerebral Ischemia-Reperfusion Injury via Regulation of the AMPK/CREB/BDNF Pathway.

Authors:  Ke Liu; Lulu Li; Zhijun Liu; Gang Li; Yanqing Wu; Xingjun Jiang; Mengdie Wang; Yanmin Chang; Tingting Jiang; Jianheng Luo; Jiahui Zhu; Hongge Li; Yong Wang
Journal:  Front Pharmacol       Date:  2022-04-01       Impact factor: 5.988

7.  Cerebral Blood Flow of the Neonatal Brain after Hypoxic-Ischemic Injury.

Authors:  Luis Octavio Tierradentro-García; Sandra Saade-Lemus; Colbey Freeman; Matthew Kirschen; Hao Huang; Arastoo Vossough; Misun Hwang
Journal:  Am J Perinatol       Date:  2021-07-05       Impact factor: 1.862

8.  Increased apoptosis, tumor necrosis factor-α, and DNA damage attenuated by 3',4'-dihydroxyflavonol in rats with brain İschemia-reperfusion.

Authors:  Dervis Dasdelen; Merve Solmaz; Esma Menevse; Rasim Mogulkoc; Abdulkerim Kasim Baltaci; Ender Erdogan
Journal:  Indian J Pharmacol       Date:  2021 Jan-Feb       Impact factor: 1.200

9.  Inhibition of serum and glucocorticoid regulated kinases by GSK650394 reduced infarct size in early cerebral ischemia-reperfusion with decreased BBB disruption.

Authors:  Oak Z Chi; Antonio Chiricolo; Xia Liu; Nikhil Patel; Estela Jacinto; Harvey R Weiss
Journal:  Neurosci Lett       Date:  2021-07-29       Impact factor: 3.197

10.  Normobaric Oxygen (NBO) Therapy Reduces Cerebral Ischemia/Reperfusion Injury through Inhibition of Early Autophagy.

Authors:  Meng Wang; Xiaokun Geng; Chaitu Dandu; Radhika Patel; Yuchuan Ding
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-30       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.